Susan McClure

Susan is on a mission to help people understand how their lives are changing thanks to our increased understanding of our own DNA. Her life's work is centered around helping people make informed decisions about their health by improving their health literacy.

Prior to joining Genetic Alliance, Susan served as the founder and CEO of Genome Creative—a media consulting company committed to that mission. She was also the founder and publisher of Genome magazine—a first-in-class consumer magazine covering all aspects of the movement toward precision medicine and the genomic revolution making it possible.

Prior to its launch, she spent 10 years as the publisher of CURE — a magazine for cancer patients, survivors, and caregivers. During her tenure at CURE, she served as vice president of patient engagement for McKesson Specialty Health. Under Susan’s direction, she and her team were honored for outstanding journalism by many professional media organizations, including Folio, the American Society of Magazine Editors, the American Cancer Society, Magazine Publishers of America, and Media Industry News.

In 2016, Susan was honored by Folio as one of the “Top Women in Media” and was invited by the Personalized Medicine Coalition to its board of directors — the first journalist to receive such an honor. She also serves as a founding board member of FT3 (From Testing to Targeted Treatments) -- a global, open, and collaborative multi-stakeholder program intended to build synergies and accelerate pragmatic efforts to make personalized medicine an accessible reality for all patients who could benefit from it. She co-leads the program's education and awareness working group.